Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1.56 USD | -6.02% | -11.36% | -76.69% |
Kurzporträt
Mitarbeiterzahl: 13
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Wendy Guy
FOU | Founder | 59 | 29.03.11 |
Sian Bigora
FOU | Founder | 63 | 29.03.11 |
David Young
FOU | Founder | 71 | 29.03.11 |
Patrick Lin
FOU | Founder | 58 | 29.03.11 |
George Ng
CEO | Chief Executive Officer | 49 | 08.08.23 |
Jim Stanker
DFI | Director of Finance/CFO | 67 | 05.09.18 |
Weifei Ye
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kayla Parks
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Mary Nyberg
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
George Ng
CEO | Chief Executive Officer | 49 | 08.08.23 |
James Neal
BRD | Director/Board Member | 68 | 16.07.22 |
Justin Yorke
CHM | Chairman | 58 | 02.10.17 |
Patrick Lin
FOU | Founder | 58 | 29.03.11 |
David Young
FOU | Founder | 71 | 29.03.11 |
Director/Board Member | 66 | 11.07.22 | |
Geraldine Pannu
BRD | Director/Board Member | 54 | 13.02.20 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 2 860 981 | 2 534 087 ( 88,57 %) | 5 000 ( 0,1748 %) | 88,57 % |
Unternehmenskontakt
Processa Pharmaceuticals, Inc.
7380 Coca Cola Drive Suite 106
21076, Hanover
+
http://www.processapharma.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-76.69% | 4.46 Mio. | |
+27.97% | 672 Mrd. | |
+23.68% | 550 Mrd. | |
-7.02% | 351 Mrd. | |
+14.85% | 317 Mrd. | |
+6.25% | 292 Mrd. | |
+2.17% | 211 Mrd. | |
-0.31% | 203 Mrd. | |
-11.81% | 144 Mrd. | |
-8.80% | 141 Mrd. |
- Börse
- Aktien
- A40161 Aktie
- Unternehmen Processa Pharmaceuticals, Inc.